Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted August 6, 2013
Weight Loss Supplement Recall Expanded
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Quick Thin and Bethel Advance were sold directly to consumers in Bethel Nutritional's New York, NY, sales office and online at www.bethel30.com. The supplements are packaged in white plastic bottles containing 30 capsules each, and can be identified by the following:
Quick Thin Lot # 10032011 and Expiration Date 10/2014
Bethel Advance Lot # 10092011 and Expiration Date 2014
(See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.)
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See Related Warnings
For more information about this recall, use the link below.